CXCL8 and systemic lupus erythematosus: Akin to that observed in an array of other pathologic conditions ranging from preeclampsia and SLE to cancer and RA[8,9,12,13,17], PMNs from RA patients exhibited an increased response to further stimulation (for instance, by treatment with IL-8, the phorbol ester PMA, or with LPS).